• 971551792927
  • info-ucg@utilitarianconferences.com
Login
WhatsApp

Track 45: Adaptive Clinical Trials

Track 45: Adaptive Clinical Trials

Overview: Adaptive Clinical Trials

Adaptive clinical trials are a modern trial design approach that allows pre-planned modifications to the trial procedures or parameters based on interim data analysis without compromising the trial’s integrity or validity. Unlike traditional fixed designs, adaptive trials provide flexibility to respond to emerging data while the study is ongoing. These modifications can include changes in sample size, treatment arms, dosing regimens, patient eligibility criteria, or even the early termination of ineffective arms. This approach enhances efficiency, ethical standards, and resource utilization, making it particularly valuable in oncology, rare diseases, and emergency response research (e.g., pandemics).

Key Sub-Topics in Adaptive Clinical Trials:

Interim Data Monitoring · Sample Size Re-estimation · Dose-Finding and Escalation Designs · Response-Adaptive Randomization · Seamless Phase II/III Trials · Drop-the-Loser Designs · Enrichment Strategies · Adaptive Bayesian Designs · Group Sequential Designs · Platform Trials · Basket and Umbrella Trials · Master Protocols · Regulatory Guidance on Adaptive Designs · Statistical Methods and Simulation Modeling · Ethical Considerations in Adaptive Trials


Adaptive clinical trials represent a paradigm shift in clinical research, supporting faster decision-making, improved patient safety, and a higher likelihood of clinical and regulatory success.

Let me know if you'd like an infographic or visual summary to go along with this overview.